SARAH WHITE: Open Payments
NPI 1053638304 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,735 in 138 payments from 23 companies in 2025. Trend: 2023 $3,146 · 2024 $2,099 · 2025 $2,735
Food & beverage: $2,680Education: $55
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 37 | $540 |
| Novartis Pharmaceuticals Corporation | 21 | $440 |
| UCB, Inc. | 9 | $335 |
| Janssen Biotech, Inc. | 15 | $300 |
| Mallinckrodt Hospital Products Inc. | 12 | $221 |
| ANI Pharmaceuticals, Inc. | 9 | $191 |
| PFIZER INC. | 9 | $182 |
| Radius Health, Inc. | 5 | $110 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
Products named: COSENTYX, Bimzelx, TREMFYA, ACTHAR, KRYSTEXXA, PURIFIED CORTROPHIN GEL, OTEZLA, XELJANZ.
Industry payments across TX — which companies pay providers there.
